Pharmacological modulation of TSPO in microglia/macrophages and neurons in a chronic neurodegenerative model of prion disease

Author:

Vicente-Rodríguez Marta,Mancuso Renzo,Peris-Yague Alba,Simmons Camilla,Wlazly Dominika,Dickinson Amber,Foster Andy,Knight Clare,Leckey Claire,Morgan Paul,Morgan Angharad,O’Hagan Caroline,Touchard Samuel,Khan Shahid,Murphy Phil,Parker Christine,Patel Jai,Richardson Jill,Acton Paul,Austin Nigel,Bhattacharya Anindya,Carruthers Nick,de Boer Peter,Drevets Wayne,Isaac John,Jones Declan,Kemp John,Kolb Hartmuth,Nye Jeff,Wittenberg Gayle,Barker Gareth,Bogdanova Anna,Byrom Heidi,Cattaneo Annamaria,Enache Daniela,Gee Tony,Hastings Caitlin,Kose Melisa,Lombardo Giulia,Mariani Nicole,McLaughlin Anna,Mondelli Valeria,Nettis Maria,Nikkheslat Naghmeh,Pariante Carmine,Randall Karen,Schubert Julia,Sforzini Luca,Sheridan Hannah,Singh Nisha,Van Loo Vicky,Veronese Mattia,Wood Toby,Worrell Courtney,Zajkowska Zuzanna,Campbell Brian,Egebjerg Jan,Eriksson Hans,Gastambide Francois,Adams Karen Husted,Jeggo Ross,Moeller Thomas,Nelson Bob,Plath Niels,Thomsen Christian,Pederson Jan Torleif,Zorn Stevin,Deith Catherine,Farmer Scott,McClean John,McPherson Andrew,Penandes Nagore,Scouller Paul,Sutherland Murray,Attenburrow Mary Jane,Benjamin Jithen,Jones Helen,Mada Fran,Oladejo Akintayo,Smith Katy,Balice-Gordon Rita,Binneman Brendon,Duerr James,Fullerton Terence,Goli Veeru,Hughes Zoe,Piro Justin,Samad Tarek,Sporn Jonathan,Hoskins Liz,Kohn Charmaine,Wilcock Lauren,Aigbirhio Franklin,Bhatti Junaid,Bullmore Ed,Chamberlain Sam,Correia Marta,Crofts Anna,Fryer Tim,Graves Martin,Hatton Alex,Kitzbichler Manfred,Lynall Mary-Ellen,Maurice Christina,O’Donnell Ciara,Pointon Linda,Hyslop Peter St George,Turner Lorinda,Vertes Petra,Widmer Barry,Williams Guy,Cavanagh Jonathan,McColl Alison,Shaw Robin,Boddeke Erik,Baird Alison,Clare Stuart,Cowen Phil,Huang I-Shu,Hurley Sam,Nevado-Holgado Alejo,Ribe Elena,Vyas Anviti,Winchester Laura,Cleal Madeleine,Gomez-Nicola Diego,Perry Hugh,Cercignani Mara,Clarke Charlotte,Colasanti Alessandro,Harrison Neil,Murray Rosemary,O’Connor Jason,Mount Howard,Gómez-Nicola Diego,Perry V. Hugh,Turkheimer Federico,Lovestone Simon,Parker Christine A.,Cash Diana,

Abstract

AbstractNeuroinflammation is an important component of many neurodegenerative diseases, whether as a primary cause or a secondary outcome. For that reason, either as diagnostic tools or to monitor progression and/or pharmacological interventions, there is a need for robust biomarkers of neuroinflammation in the brain. Mitochondrial TSPO (18 kDa Translocator protein) is one of few available biomarkers of neuroinflammation for which there are clinically available PET imaging agents. In this study, we further characterised neuroinflammation in a mouse model of prion-induced chronic neurodegeneration (ME7) including a pharmacological intervention via a CSF1R inhibitor. This was achieved by autoradiographic binding of the second-generation TSPO tracer, [3H]PBR28, along with a more comprehensive examination of the cellular contributors to the TSPO signal changes by immunohistochemistry. We observed regional increases of TSPO in the ME7 mouse brains, particularly in the hippocampus, cortex and thalamus. This increased TSPO signal was detected in the cells of microglia/macrophage lineage as well as in astrocytes, endothelial cells and neurons. Importantly, we show that the selective CSF1R inhibitor, JNJ-40346527 (JNJ527), attenuated the disease-dependent increase in TSPO signal, particularly in the dentate gyrus of the hippocampus, where JNJ527 attenuated the number of Iba1+ microglia and neurons, but not GFAP+ astrocytes or endothelial cells. These findings suggest that [3H]PBR28 quantitative autoradiography in combination with immunohistochemistry are important translational tools for detecting and quantifying neuroinflammation, and its treatments, in neurodegenerative disease. Furthermore, we demonstrate that although TSPO overexpression in the ME7 brains was driven by various cell types, the therapeutic effect of the CSF1R inhibitor was primarily to modulate TSPO expression in microglia and neurons, which identifies an important route of biological action of this particular CSF1R inhibitor and provides an example of a cell-specific effect of this type of therapeutic agent on the neuroinflammatory process.

Funder

GlaxoSmithKline

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Neurology,Immunology,General Neuroscience

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3